AOCC 2020 Virtual & Onsite

S01. AOCC Education Workshop: Tips from an expert

Room 3, December 16 (Wed), 09:00-10:30

more

09:00-09:20	Diagnosis of IBD: Clinical perspective Ida Hilmi, , Malaysia
09:20-09:40	Differential diagnosis of IBD: A pathologist's advice Jihun Kim, University of Ulsan, Korea
09:40-10:00	Role of conventional medications in the biologic era Yue Li, Peking Union Medical College Hospital, China
10:00-10:20	Optimization of IBD therapeutics by evolving treatment goals Miguel Regueiro, Cleveland Clinic, USA
10:20-10:30	Discussion

S02. Current issues of IBD in Asia

Room 1, December 16 (Wed), 10:50-12:20

more

10:50-11:10	Epidemiological trends of IBD: What is new? Siew Chien Ng, The Chinese University of Hong Kong, Hong Kong
11:10-11:30	Diagnostic challenges of IBD: How to differentiate IBD mimics? Zhihua Ran, Shanghai Jiao-Tong University School of Medicine, China
11:30-11:50	Smart use of thiopurine and anti-TNF: What should we know? Tadakazu Hisamatsu, Kyorin University, Japan
11:50-12:05	Abstract
12:05-12:20	Abstract

S03. New frontiers in the pathogenesis of IBD

Room 2, December 16 (Wed), 10:50-12:20

more

10:50-11:10	Recent updates on genetics research and its clinical implications Dermot P.B. McGovern, Cedars-Sinai Medical Center, USA
11:10-11:30	Crosstalk between microbiome and host immune system
11:30-11:50	Mucosal immune response and novel therapeutic targets Jae Hee Cheon, Yonsei University, Korea
11:50-12:10	Cellular and molecular mechanisms of intestinal fibrosis Ren Mao, The First Affiliated Hospital of Sun Yat-sen University, China
12:10-12:20	Discussion

S04. Up-to-date radiological imaging in IBD

Room 3, December 16 (Wed), 10:50-12:20

more

10:50-11:10	Update on the role of CT enterography Se Hyung Kim, Seoul National University, Korea
11:10-11:30	Current status and future directions of MR Enterography Seong Ho Park, University of Ulsan, Korea
11:30-11:50	Ultrasonography as an emerging tool for IBD Jiro Hata, Kawasaki Medical School, Japan
11:50-12:05	Abstract
12:05-12:20	Abstract

S05. Microbiome in IBD: Friends or foes?

Room 1, December 16 (Wed), 13:40-15:10

more

13:40-14:00	Good bugs and bad bugs in colitis and colitis-associated cancer Christian Jobin, University of Florida, USA
14:00-14:20	Viruses and fungi in the pathogenic and therapeutic perspectives
14:20-14:40	FMT: Where are we now and where are we going? Young-Seok Cho, The Catholic University of Korea, Korea
14:40-15:00	The future of microbiome engineering for IBD treatment Harry Sokol, Saint-Antoine Hospital, France
15:00-15:10	Discussion

S06. Recent advances in diagnosis and monitoring of IBD

Room 2, December 16 (Wed), 13:40-15:10

more

13:40-14:00	Optimal diagnosis in IBD: What will it change? Silvio Danese, Humanitas Research Hospital, Italy
14:00-14:20	Emerging roles of biomarkers in IBD Shiro Nakamura, 2nd Department of Internal Medicine, Osaka Medical College, Japan
14:20-14:40	Therapeutic drug monitoring: How, when, and for whom? Jia-Feng Wu, National Taiwan University Hospital, Taiwan
14:40-14:55	Abstract
14:55-15:10	Abstract

S07. Looking into the operating room of IBD surgeons

Room 3, December 16 (Wed), 13:40-15:10

more

13:40-14:00	Evolving role of IBD surgery Willem A. Bemelman, Amsterdam University Medical Centers, Netherlands
14:00-14:20	Total proctocolectomy in UC: Tips for laparoscopic surgery Seung-Bum Ryoo, Seoul National University, Korea
14:20-14:40	Perianal Crohn’s disease: Surgical options to save anus
14:40-15:00	Experiences of IBD Surgery in the era of biologics Kil Yeon Lee, Kyung Hee University, Korea
15:00-15:10	Discussion

S08. ECCO-AOCC Forum 2020

Room 1, December 16 (Wed), 15:30-17:00

more

15:30-15:45	Part 1. Acute severe UC Optimal strategies for drug therapy: Which one, when, and how? Hiroshi Nakase, Sapporo Medical University, Japan
15:45-16:00	Part 1. Acute severe UC Review of outcome predictors: prognosticators and available indices Silvio Danese, Humanitas Research Hospital, Italy
16:00-16:15	Part 1. Acute severe UC State of the art for surgical treatment Kyu Joo Park, Seoul National University, Korea
16:15-16:30	Part 2. Small bowel CD Identification of stricture characteristic using cross sectional images: inflammatory vs fibrotic Se Hyung Kim, Seoul National University, Korea
16:30-16:45	Part 2. Small bowel CD Nonsurgical therapies: drugs and balloon Takayuki Matsumoto, Iwate Medical University, Japan
16:45-17:00	Part 2. Small bowel CD Surgical treatment: optimal timing, preparation, and technique Willem A. Bemelman, Amsterdam University Medical Centers, Netherlands

S09. Multidisciplinary approach in challenging cases

Room 2, December 16 (Wed), 15:30-17:00

more

	Panel discussion: Gastroenterologist, (Pediatrician (chair), Surgeon (chair)) Seong Ho Park, University of Ulsan, Korea (Radiologist)
15:30-16:00	Surgeon’s perspective for complicated CD Yong Sik Yoon, University of Ulsan, Korea
16:00-16:30	Cutting-edge issues in Pediatric IBD Yeoun Joo Lee, Pusan National University, Korea
16:30-17:00	Optimal management for colitis-associated rectal cancer Su Young Kim, Yonsei University Wonju, Korea

Scientific Program